461 Individualized molecular profiling for allocation to clinical trials (impact) - experience from an Asian tertiary cancer centre von Seet, A, Lim, W.T, Ng, M, Tai, D.W.M, Tan, G.S, Krisna, S.S, Gogna, A, Yew, X.Y, Wong, V.L.L, Lim, T.H, Aung, Z.W, Lim, A, Takano, A, Tan, E.H, Lim, K.H.T, Tan, D.S.W

Volltext

P37.18 Lung NSCLC Molecular Diagnostic Comparison Between NGS and Multiplex PCR Assays von Lim, K.H.T., Tan, G.S., Tan, D., Tan, A., Chen, E.

Volltext

FRI-161 - Presence of steatosis does not increase the risk of Hepatocellular Carcinoma in patients with Chronic Hepatitis B over long follow-up von Lim, C.T., Goh, B.B.G., Lim, K.H.T., Leow, W.Q., Azhar, R., Wan, W.K., Kumar, R.

Volltext

Presence of steatosis does not increase the risk of Hepatocellular Carcinoma in patients with Chronic Hepatitis B over long follow-up von Lim, C.T., Goh, B.B.G., Lim, K.H.T., Leow, W.Q., Azhar, R., Wan, W.K., Kumar, R.

Volltext

P59.08 THOR: Multi-Ethnic, Open Access Thoracic Cancer Genomics Resource von Alvarez, J., Chua, K.P., Sim, N.L., Abedi, M., Chen, J., Tan, A., Lai, G., Takano, A., Lim, W., Tan, E., Lim, K.H.T., Zhai, W., Tan, D., Skanderup, A.

Volltext

P69.05 Molecular and Cellular Heterogeneity Underpin Treatment Response Across a Spectrum of EGFR-Mutant Non-Small Cell Lung Cancer von Yuan, J., Lim, E., Ma, S.M., Chua, K.P., Lee, Y.F., Lim, M.J., Yeo, X.H., Phua, C., Takano, A., Aung, Z., Lim, K.H.T., Tan, E., Tan, D., Chew, G.L., Tam, W.L.

Volltext

FP14.13 Molecular Characterisation and Clinical Outcomes in RET Rearranged Non-Small Cell Lung Cancer (NSCLC) von Tan, A., Lai, G., Tan, G.S., Seet, A., Takano, A., Alvarez, J., Skanderup, A., Tan, W., Ang, M., Kanesvaran, R., Ng, Q.S., Jain, A., Rajasekaran, T., Lim, W., Tan, E., Lim, K.H.T., Tan, D.

Volltext

P76.88 Real-World Data of Osimertinib in Patients with Metastatic EGFRm+ NSCLC who Progressed on First-Line EGFR TKIs von Ma, J., Tan, S.H., Yin, D., Tran, A., Tan, D., Ang, M., Takano, A., Lim, K.H.T., Kanesvaran, R., Jain, A., Rajasekaran, T., Tan, E., Lim, D.W., Ng, Q.S., Tan, W.

Volltext

P38.03 Immunohistochemical, Histologic and Genomic Characterisation of Early Stage Pulmonary Invasive Mucinous Adenocarcinoma von Tan, A., Ong, B., Koh, T., Chen, J., Oo, H.N., Lai, G., Tan, W., Ang, M., Kanesvaran, R., Ng, Q.S., Jain, A., Rajasekaran, T., Zhai, W., Skanderup, A., Lim, K.H.T., Tan, E., Lim, W., Tan, D., Takano, A.

Volltext

OA01.06 Randomised Phase 2 Study of Nivolumab (N) Versus Nivolumab and Ipilimumab (NI) Combination in EGFR Mutant NSCLC von Lai, G., Alvarez, J., Yeo, J.C., Sim, N.L., Tan, A., Zhou, S., Suteja, L., Lim, T.W., Rohatgi, N., Yeong, J., Takano, A., Lim, K.H.T., Gogna, A., Too, C.W., Zhuang, K.D., Jain, A., Tan, W., Kanesvaran, R., Ng, Q.S., Ang, M., Rajasekaran, T., Wang, L., Toh, C.K., Lim, W., Tam, W.L., Ginhoux, F., Tan, S.H., Skanderup, A., Tan, D., Tan, E.

Volltext

OA06.05 Molecular and Clinical Features Associated with Relapse in Early Stage EGFR-Mutated NSCLC: A Single Institution Knowledge Bank von Saw, S.P.L., Lai, G., Zhou, S., Chen, J., Ang, M., Chua, K., Kanesvaran, R., Ng, Q.S., Jain, A., Tan, W., Rajasekaran, T., Lim, D.W., Fong, K.W., Takano, A., Cheng, X.M., Lim, K.H.T., Koh, T., Ong, B.H., Tan, E., Skanderup, A., Tan, D.

Volltext

MA13.08 Genomic and Transcriptomic Features of Distinct Resistance Trajectories in EGFR Mutant Non-Small Cell Lung Cancer (NSCLC) von Tan, A., Chua, K.P., Teng, Y., Takano, A., Alvarez, J., Nahar, R., Rohatgi, N., Lai, G., Aung, Z., Yeong, J., Lim, K.H.T., Naeini, M., Kassam, I., Jain, A., Tan, W., Gogna, A., Too, C.W., Kanesvaran, R., Ng, Q.S., Ang, M., Rajasekaran, T., Devanand, A., Phua, G.C., Tan, B.S., Lee, Y.Y., Wang, L., Teo, A., Khng, A., Lim, M.J., Suteja, L., Toh, C.K., Lim, W., Iyer, N.G., Tam, W.L., Tan, E., Zhai, W., Hillmer, A., Skanderup, A., Tan, D.

Volltext